PATH
Menu

Filter browse results

Total results with these characteristics: 329

Subject: Vaccines and immunization
Publication date: All

Page 10 of 17
Producing a Successful Malaria Vaccine: Innovation in the Lab and Beyond

Late-stage trials of an advanced malaria vaccine candidate—which, if approved, would become the world’s first malaria vaccine—are under way. This article, published in Health Affairs, recounts the pivotal roles played by collaborations of nonprofit organizations, pharmaceutical companies, private and public donors, and countries whose citizens would benefit most directly from a vaccine.

Author: Loucq C, Birkett A, Poland D, Botting C, Nunes J, Ethelston S

Publication date: June 2011

Region: Africa

Staying the Course? Malaria Research and Development in a Time of Economic Uncertainty

This report details malaria research and development funding from 2004 to 2009, including how much funding went to each product area, who provided the funding, and how investments flowed from funders to recipients. The report assesses progress against the Global Malaria Action Plan funding goals to identify what is needed in the next decade and was followed in 2013 by From Pipeline to Product: Malaria R&D Funding Needs Into the Next Decade.

Publication date: June 2011

Region: Global

Community Perceptions of Malaria and Vaccines in the South Coast and Busia Regions of Kenya

Malaria is a leading cause of morbidity and mortality in children younger than five years in Kenya. Within the context of planning for a vaccine to be used alongside existing malaria control methods, this study, published in Malaria Journal, explores sociocultural and health communications issues among individuals who are responsible for or influence decisions on childhood vaccination at the community level.

Author: Ojakaa DI, Ofware P, Machira YW, et al

Publication date: May 2011

Region: Africa

Directions in Global Health (Volume 8, Issue 1)

This issue of Directions in Global Health features PATH’s work related to vaccines and immunization. Articles cover the development and introduction of a vaccine to eliminate epidemic meningitis in Africa, use of vaccines and other interventions to prevent cervical cancer, transformation of vaccine distribution systems, expansion of access to rotavirus vaccines, and advancements in vaccine technologies.

Publication date: May 2011

Region: Global

Part of series: Directions in Global Health

PATH Today (Spring 2011)

Featured in this issue of PATH Today are stories and photos from the historic launch of a new meningitis vaccine in Burkina Faso. Also included are updates on projects receiving support from the Catalyst Fund, announcement of a seventh consecutive top rating from Charity Navigator, and a spotlight on Breakfast for Global Health sponsor CB Richard Ellis.

Publication date: May 2011

Region: Global

Part of series: PATH Today

Recent Evidence on Cervical Cancer Screening in Low-Resource Settings

This Alliance for Cervical Cancer Prevention fact sheet summarizes evidence published since 2009 on cervical cancer screening approaches for low-resource settings.

Publication date: May 2011

Region: Global

Understanding Influenza Vaccine Effectiveness in Senegal

This fact sheet describes a phase 4, post-licensure influenza vaccine effectiveness study that PATH and its partners are conducting in Senegal. The study seeks to better understand the extent of the influenza disease burden in tropical Africa, as well as the potential of current seasonal influenza vaccines to reduce influenza-related deaths in the developing world. Ultimately, study data could help public health officials decide how to best use influenza vaccines in Senegal and in similar tropical countries.

Publication date: May 2011

Region: Africa

Vesikari Clinical Severity Scoring System Manual

This manual provides a suggested standardized methodology for implementing the Vesikari Clinical Severity Scoring System across rotavirus vaccine studies. It provides details on scoring system parameters, identifies implementation challenges, and presents instructions for collecting symptom information and using the accompanying template Case Report Form and diary cards.

Author: Lewis K

Publication date: May 2011

Region: Global

Assessment of the Vaccine Supply Chain for Fee-Based Immunization in Hanoi Capital and Ho Chi Minh City

The objective of this project Optimize assessment was to understand the structure, scope, and quality of the vaccine supply chain for fee-based immunization services and to provide recommendations for strengthening management and monitoring the quality of the vaccine supply chain for fee-based immunization.

Publication date: April 2011

Region: Asia

Progress in Cervical Cancer Prevention: The CCA Report Card

This report assesses global readiness to fight cervical cancer using new approaches and new technologies, especially in regions where the disease is a common killer. It underscores the urgent need for the global community to prioritize cervical cancer prevention and control on global health and development agendas.

Publication date: April 2011

Region: Global

The Case for Investment in Enterotoxigenic Escherichia coli Vaccines

This market assessment aims to increase the awareness of biotechnology and pharmaceutical companies worldwide about the opportunities and potential markets that exist for low-cost and effective vaccines against enterotoxigenic Escherichia coli (ETEC). In addition, it provides donors and commercial investors with a better understanding of the potential risks, rewards, and gaps in knowledge relative to these opportunities as they consider their own investment strategies. The resulting analysis demonstrates that ETEC vaccines may represent a moderate opportunity for industry investment with an estimated annual revenue potential of more than US$600 million ten years after global launch.

Publication date: March 2011

Region: Global

HPV Vaccination in Africa: Lessons Learned From a Pilot Program in Uganda

This report summarizes the human papillomavirus (HPV) vaccination program implemented in Uganda by PATH, the Uganda National Expanded Program on Immunization of the Ministry of Health, and the Child Health and Development Centre, through the HPV Vaccines: Evidence for Impact project. HPV vaccine was made available to almost 10,000 girls in select parts of the country. The purpose of the study was to investigate operational issues related to HPV vaccination of young adolescent girls, aimed at identifying effective and cost-effective strategies. This report interprets the results and summarizes helpful lessons for policymakers and program managers, especially those in sub-Saharan Africa, looking to shape their own HPV vaccination programs. To see other reports in this series, visit the RHO Cervical Cancer website.

Publication date: January 2011

Region: Global

Part of series: HPV vaccination project lessons learned reports

Vaccine Vial Monitors: FAQs

Vaccine vial monitors (VVMs) are small stickers that adhere to vaccine vials and change color as the vaccine is exposed to heat, letting health workers know whether the vaccine can be safely used for immunization. This fact sheet answers the most frequently asked questions regarding VVMs.

Publication date: January 2011

Region: Global

Implementing HPV Vaccination Programs: Practical Experience From PATH

This report is part of the Cervical Cancer Prevention: Practical Experience Series on the RHO Cervical Cancer website. It offers practical information to countries that plan to pilot, expand, or scale up human papillomavirus (HPV) vaccination programs. The main focus is on issues specific to HPV vaccination, such as working with a young adolescent target population in school settings and developing community support for HPV vaccination programs.

Publication date: 2011

Region: Global

Strategic Planning and Situation Assessment for Cervical Cancer Prevention: Practical Experience From PATH

This report is part of the Cervical Cancer Prevention: Practical Experience Series on the RHO Cervical Cancer website. It aims to help decision-makers and program planners focus on key “big picture” questions about cervical cancer prioritization and on opportunities and challenges for improved cancer prevention, including vaccination of girls and precancer screening and treatment of adult women.

Publication date: 2011

Region: Global

Evaluating HPV Vaccine Delivery Strategies in Vietnam

This report is a synthesis of the project Evaluating HPV Vaccine Delivery Strategies in Vietnam, which aimed to identify appropriate strategies for human papillomavirus (HPV) vaccine delivery in different geographic and socioeconomic conditions. The report summarizes results of both the implementation and research aspects of the project. The document is available as one large file or as four smaller files for easier downloading.

Publication date: December 2010

Region: Asia

HPV Vaccination in Latin America: Lessons Learned From a Pilot Program in Peru

This report summarizes the human papillomavirus (HPV) vaccination program implemented in Peru by PATH, Instituto de Investigación Nutricional, and Ministerio de Salud de Peru, Estrategia Sanitaria Nacional de Inmunizaciones through the HPV Vaccines: Evidence for Impact project. HPV vaccine was made available to all girls aged nine years or older in grade 5 in selected parts of the country. The purpose of the study was to investigate operational issues related to HPV vaccination of young adolescent girls, aimed at identifying effective and cost-effective strategies. The publication will be useful for policymakers and program managers around the world, and especially in Latin America, who are designing public-sector HPV vaccination programs. To see other reports in this series, visit the RHO Cervical Cancer website.

Publication date: December 2010

Region: Global

Part of series: HPV vaccination project lessons learned reports

Japanese Encephalitis Vaccine Introduction in Cambodia

This fact sheet describes PATH's partnership with Cambodia's Ministry of Health to conduct sentinel surveillance on Japanese encephalitis and introduce a vaccine in 2009.

Publication date: December 2010

Region: Asia

PATH Today (Winter 2010)

This issue of PATH Today focuses on the launch of the MenAfriVac™ vaccine, the first meningitis vaccine created specifically for Africa. The issue includes a timeline of meningitis in Africa and the development of the vaccine, how PATH partnered with other organizations to create an affordable solution, and a glimpse of what life is like in the "meningitis belt."

Publication date: December 2010

Region: Global

Part of series: PATH Today

Collaborating With Countries to Improve Supply Chains

Project Optimize—a collaboration between the World Health Organization and PATH—aims to employ technological and scientific advances in the immunization field. This document describes efforts to define ideal specifications for health products and create a flexible and robust vaccine supply chain that can handle an increasingly large and costly portfolio of vaccines.

Publication date: November 2010

Region: Global

Page 10 of 17